Key Insights

Highlights

Treatment Research

3 treatments under study, led by Bronchoscopy Training Simulator Lm092 Koken Co Ltd Tokyo Japan

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Not Yet Recruiting1
Unknown1

Clinical Trials (2)

Research Network

Common Treatments

  • Bronchoscopy Training Simulator Lm092 Koken Co Ltd Tokyo Japan1
  • The Bronch Mentor Simbionix Gibronch Mentor Usa1
  • Neonatal Umbilical Catheter Pathway Simulator1

Active Sponsors

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
  • Southeast University, China1

Top Investigators

Related Conditions

  • Catherization1
  • Neonates And Preterm Infants1

Activity Timeline